This article is more than 5 years old. Information may no longer be current.

FDA approves intervertebral body fusion device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Binder Biomedical Inc. announced that the FDA has cleared its LOGIC, a stand-alone intervertebral body fusion device. The device is indicated for use in patients with degenerative disc disease at one or two contiguous levels of the lumbosacral spine.

LOGIC is an implant that works as a complete anterior lumbar fixation system with a simple, one-step locking mechanism. The implants have large central windows for optimum autograft bone placement and come in different sizes from 10 mm to 20 mm in height. The implant is positioned into the intervertebral space and secured by screws. Alpha release is expected in the first quarter of 2014 with full launch by the end of the year.

“We are excited to bring such a streamlined device to market. Our design team has done a great job putting together such a comprehensive system, ensuring that it can be tailored to any surgeon’s preferred technique,” Lawrence Binder, CEO of Binder Biomedical Inc stated in a company press release.